XLIMus Drug Eluting Stent: a randomIzed Controlled Trial to Assess Endothelization

NCT03745053 · clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
180
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Cardionovum GmbH

Collaborators